[Market Focus] Rokit Healthcare Surges Over 10% on UAE Joint Venture Initiative

Rokit Healthcare is showing strong gains in early trading following news that the company is pursuing the establishment of a joint venture with an investment firm in the United Arab Emirates (UAE) to enter the Middle Eastern market.

As of 9:08 a.m. on April 14, Rokit Healthcare was trading at 107,000 won, up 10,400 won (10.77%) from the previous day.

On this day, Rokit Healthcare announced that it had signed a memorandum of understanding (MOU) with UAE investment institution Master Investment Group (MIG) for equity investment and the establishment of a joint venture (JV).

Under the agreement, the two companies will pursue the establishment of a Middle Eastern joint venture tentatively named “ROKIT MENA.” MIG will invest approximately 30 billion won in capital, while Rokit Healthcare will contribute its core AI organ regeneration platform technology in kind. Once the final investment contract is signed, the companies plan to initiate the establishment procedures for a local factory and the joint venture.

The joint venture will use the UAE as its base to set up AI-powered organ regeneration clinics and local production facilities, with plans to expand its medical network to key Gulf Cooperation Council (GCC) countries such as Saudi Arabia, as well as to the European market.

This content was produced with the assistance of AI translation services.